Publicaciones en las que colabora con José Luis Vila Jato (86)

2004

  1. PEG-PLA nanoparticles as carriers for nasal vaccine delivery

    Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

2000

  1. Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity

    S.T.P. Pharma Sciences, Vol. 10, Núm. 1, pp. 69-76

  2. Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules

    International Journal of Pharmaceutics, Vol. 199, Núm. 2, pp. 151-158

  3. The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration

    Colloids and Surfaces B: Biointerfaces, Vol. 18, Núm. 3-4, pp. 315

1999

  1. Chitosan devices for buccal administration of insulin

    Farmacevtski Vestnik

  2. Chitosan nanoparticles: A new vehicle for increasing the nasal absorption of peptides

    Proceedings of the Controlled Release Society

  3. Enhancement of nasal absorption of insulin using chitosan nanoparticles

    Pharmaceutical Research, Vol. 16, Núm. 10, pp. 1576-1581

1998

  1. Comparison between aqueous and non-aqueous solvent evaporation methods for microencapsulation of drug-resin complexes

    International Journal of Pharmaceutics, Vol. 173, Núm. 1-2, pp. 171-182

  2. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery

    Journal of Controlled Release, Vol. 55, Núm. 2-3, pp. 143-152

  3. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region

    Journal of Controlled Release, Vol. 55, Núm. 1, pp. 67-77

  4. Design of microencapsulated chitosan microspheres for colonic drug delivery

    Journal of Controlled Release, Vol. 52, Núm. 1-2, pp. 109-118

  5. Development of new chitosan-cellulose multicore microparticles for controlled drug delivery

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Núm. 1, pp. 49-56

  6. Effect of chitosan and chitosan glutamate enhancing the dissolution properties of the poorly water soluble drug nifedipine

    International Journal of Pharmaceutics, Vol. 175, Núm. 1, pp. 75-84

  7. Effect of norfloxacin complexation with β-cyclodextrin on the in vitro dissolution behaviour and its interaction with Mg2+ and Al3+

    Journal of Thermal Analysis and Calorimetry, Vol. 51, Núm. 3, pp. 1009-1021

1997

  1. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines

    Pharmaceutical Research, Vol. 14, Núm. 10, pp. 1431-1436

  2. Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers

    Journal of Microencapsulation, Vol. 14, Núm. 5, pp. 607-616

  3. Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions

    Colloid and Polymer Science, Vol. 275, Núm. 1, pp. 46-53

  4. Interaction of clofibrate with cyclodextrin in solution: Phase solubility, 1H NMR and molecular modelling studies

    European Journal of Pharmaceutical Sciences, Vol. 5, Núm. 4, pp. 215-221

  5. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers

    Journal of Applied Polymer Science, Vol. 63, Núm. 1, pp. 125-132

  6. Obtención de pelets por extrusión-esferonización: (I) etapas del proceso y evaluación del producto

    Industria farmacéutica: Equipos, procesos y tecnología, Núm. 2, pp. 73-78